JAGADEESH GOPALAN • Centre for Biosystems Science & Engineering, Indian Institute of
Science, Bangalore, Karnataka, India; Department of Aerospace Engineering, Indian
Institute of Science, Bangalore, Karnataka, India
ANNA GO ´ RA-SOCHACKA • Institute of Biochemistry and Biophysics, Polish Academy of Sciences,
Warsaw, Poland
YANPING GUO • Flow Cytometry Core Facility, National Heart and Lung Institute, Imperial
College London, London, UK
ZHONGWU GUO • Department of Chemistry, University of Florida, Gainesville, FL, USA
ANNA-BARBARA HACHMANN • Thermo Fisher Scientific Inc., Grand Island, NY, USA
DIPASREE HAJRA • Department of Microbiology and Cell Biology, Indian Institute of Science,
Bengaluru, India
JULIE HARNISCHFEGER • Institute of Bioprocess Engineering and Pharmaceutical Technology
(IBPT), Technische Hochschule Mittelhessen (THM) - University of Applied Sciences,
Giessen, Germany
COLIN G. HEBERT • LumaCyte, LLC, Charlottesville, VA, USA
ANDREW HILL • Department of Chemical and Biological Engineering, University at Buffalo,
The State University of New York, Buffalo, NY, USA
YOSHIKAZU HONDA-OKUBO • Vaxine Pty Ltd, Warradale, SA, Australia; College of Medicine
and Public Health, Flinders University, Adelaide, SA, Australia
SHALEEM I. JACOB • Department of Biochemical Engineering, University College London,
London, UK
YIMEI JIA • Human Health Therapeutics, National Research Council Canada, Ottawa, ON,
Canada
LUKAS K €
AßER • Institute of Bioprocess Engineering and Pharmaceutical Technology (IBPT),
Technische Hochschule Mittelhessen (THM) - University of Applied Sciences, Giessen,
Germany
PAUL J. KENNEDY • School of Computer Science, Faculty of Engineering and Information
Technology and the Centre for Artificial Intelligence, University of Technology Sydney
(UTS), Ultimo, NSW, Australia
TIMOTHY G. KEYS • Institute of Microbiology, ETH Zurich, Zurich, Switzerland
TOM A. KLOTER • Institute of Microbiology, ETH Zurich, Zurich, Switzerland
SPYRIDON KONSTANTINIDIS • Department of Biochemical Engineering, University College
London, London, UK
ATICHAT KUADKITKAN • Institute of Molecular Biosciences, Mahidol University, Nakhon
Pathom, Thailand
PUNIT KUMAR • Department of Biotechnology, University Institute of Engineering and
Technology, Maharshi Dayanand University Rohtak, Rohtak, Haryana, India;
Department of Clinical Immunology, Allergology and Microbiology, Karaganda Medical
University, Karaganda, Kazakhstan
PAUL R. LANGFORD • Section of Paediatric Infectious Disease, Department of Infectious
Disease, Imperial College London, London, UK
CATALIN LAZAR • Institute of Biochemistry of the Romanian Academy, Bucharest, Romania
LEI LI • Vaxine Pty Ltd, Warradale, SA, Australia; College of Medicine and Public Health,
Flinders University, Adelaide, SA, Australia
CHRISTA LITSCHKO • Institute of Clinical Biochemistry, Hannover Medical School,
Hannover, Germany
Contributors
xiii
Science, Bangalore, Karnataka, India; Department of Aerospace Engineering, Indian
Institute of Science, Bangalore, Karnataka, India
ANNA GO ´ RA-SOCHACKA • Institute of Biochemistry and Biophysics, Polish Academy of Sciences,
Warsaw, Poland
YANPING GUO • Flow Cytometry Core Facility, National Heart and Lung Institute, Imperial
College London, London, UK
ZHONGWU GUO • Department of Chemistry, University of Florida, Gainesville, FL, USA
ANNA-BARBARA HACHMANN • Thermo Fisher Scientific Inc., Grand Island, NY, USA
DIPASREE HAJRA • Department of Microbiology and Cell Biology, Indian Institute of Science,
Bengaluru, India
JULIE HARNISCHFEGER • Institute of Bioprocess Engineering and Pharmaceutical Technology
(IBPT), Technische Hochschule Mittelhessen (THM) - University of Applied Sciences,
Giessen, Germany
COLIN G. HEBERT • LumaCyte, LLC, Charlottesville, VA, USA
ANDREW HILL • Department of Chemical and Biological Engineering, University at Buffalo,
The State University of New York, Buffalo, NY, USA
YOSHIKAZU HONDA-OKUBO • Vaxine Pty Ltd, Warradale, SA, Australia; College of Medicine
and Public Health, Flinders University, Adelaide, SA, Australia
SHALEEM I. JACOB • Department of Biochemical Engineering, University College London,
London, UK
YIMEI JIA • Human Health Therapeutics, National Research Council Canada, Ottawa, ON,
Canada
LUKAS K €
AßER • Institute of Bioprocess Engineering and Pharmaceutical Technology (IBPT),
Technische Hochschule Mittelhessen (THM) - University of Applied Sciences, Giessen,
Germany
PAUL J. KENNEDY • School of Computer Science, Faculty of Engineering and Information
Technology and the Centre for Artificial Intelligence, University of Technology Sydney
(UTS), Ultimo, NSW, Australia
TIMOTHY G. KEYS • Institute of Microbiology, ETH Zurich, Zurich, Switzerland
TOM A. KLOTER • Institute of Microbiology, ETH Zurich, Zurich, Switzerland
SPYRIDON KONSTANTINIDIS • Department of Biochemical Engineering, University College
London, London, UK
ATICHAT KUADKITKAN • Institute of Molecular Biosciences, Mahidol University, Nakhon
Pathom, Thailand
PUNIT KUMAR • Department of Biotechnology, University Institute of Engineering and
Technology, Maharshi Dayanand University Rohtak, Rohtak, Haryana, India;
Department of Clinical Immunology, Allergology and Microbiology, Karaganda Medical
University, Karaganda, Kazakhstan
PAUL R. LANGFORD • Section of Paediatric Infectious Disease, Department of Infectious
Disease, Imperial College London, London, UK
CATALIN LAZAR • Institute of Biochemistry of the Romanian Academy, Bucharest, Romania
LEI LI • Vaxine Pty Ltd, Warradale, SA, Australia; College of Medicine and Public Health,
Flinders University, Adelaide, SA, Australia
CHRISTA LITSCHKO • Institute of Clinical Biochemistry, Hannover Medical School,
Hannover, Germany
Contributors
xiii